1
|
Malicki J, Castro CL, Fundowicz M, Krengli M, Llacer-Moscardo C, Curcean S, Montplet CM, Carvalho L, Konstanty E, Barragan TH, Pisani C, Laszlo I, Garau MM, Kruszyna-Mochalska M, Lencart J, Zwierzchowska D, Serrano AR, Brezae A, Varela EL, Milecki P, Zannetti M, Coza O, Gonzalez E, Beldì D, Guedea F. IROCA-TES: Improving Quality in Radiation Oncology through Clinical Audits - Training and Education for Standardization. Rep Pract Oncol Radiother 2023; 28:429-432. [PMID: 37795403 PMCID: PMC10547405 DOI: 10.5603/rpor.a2023.0035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2023] [Accepted: 05/23/2023] [Indexed: 10/06/2023] Open
Abstract
Background Clinical audits are an important tool to objectively assess clinical protocols, procedures, and processes and to detect deviations from good clinical practice. The main aim of this project is to determine adherence to a core set of consensus- based quality indicators and then to compare the institutions in order to identify best practices. Materials and methods We conduct a multicentre, international clinical audit of six comprehensive cancer centres in Poland, Spain, Italy, Portugal, France, and Romania as a part of the project, known as IROCATES (Improving Quality in Radiation Oncology through Clinical Audits - Training and Education for Standardization). Results Radiotherapy practice varies from country to country, in part due to historical, economic, linguistic, and cultural differences. The institutions developed their own processes to suit their existing clinical practice. Conclusions We believe that this study will contribute to establishing the value of routinely performing multi-institutional clinical audits and will lead to improvement of radiotherapy practice at the participating centres.
Collapse
Affiliation(s)
- Julian Malicki
- Electroradiology Department, University of Medical Sciences, Poznan, Poland
- Greater Poland Cancer Centre, Poznan, Poland
| | - Carla Lopes Castro
- Department of Radiotherapy, Instituto Português de Oncologia do Porto Francisco Gentil, Portugal
| | | | - Marco Krengli
- Department of Radiation Oncology, University Hospital “Maggiore della Carità”, Novara, Italy
- Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
| | | | - Sebastian Curcean
- Department of Radiation Oncology, Ion Chiricuta Institute of Oncology, Cluj-Napoca, Romania
| | - Carles Muñoz Montplet
- Department of Medical Physics and Radiation Protection, Catalan Institute of Oncology, Girona, Spain
| | - Luisa Carvalho
- Department of Radiotherapy, Instituto Português de Oncologia do Porto Francisco Gentil, Portugal
| | - Ewelina Konstanty
- Medical Physics Department, The Greater Poland Cancer Centre, Poznan, Poland
| | - Tania Hernandez Barragan
- Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, Mexico
| | - Carla Pisani
- Department of Radiation Oncology, University Hospital “Maggiore della Carità”, Novara, Italy
| | - Istvan Laszlo
- Department of Radiation Oncology, Ion Chiricuta Institute of Oncology, Cluj-Napoca, Romania
| | - Miquel Macià Garau
- Department of Radiation Oncology, Catalan Institute of Oncology, Barcelona, Spain
| | - Marta Kruszyna-Mochalska
- Electroradiology Department, University of Medical Sciences, Poznan, Poland
- Medical Physics Department, The Greater Poland Cancer Centre, Poznan, Poland
| | - Joana Lencart
- Medical Physics Service & Medical Physics, Radiobiology and Radiation Protection Group CI-IPOP, Instituto Português de Oncologia do Porto
| | | | | | | | - Eva Loureiro Varela
- Department of Information Systems, Catalan Institute of Oncology, (ICO) Barcelona, Spain
| | - Piotr Milecki
- Electroradiology Department, University of Medical Sciences, Poznan, Poland
- Radiotherapy Ward I, Greater Poland Cancer Centre, Poznan, Poland
| | - Micol Zannetti
- Department of Radiation Oncology, University Hospital “Maggiore della Carità”, Novara, Italy
| | - Ovidiu Coza
- Department of Radiotherapy with High Energies and Brachytherapy, Oncology Institute “Prof. Dr. Ion Chiricuta”, Cluj-Napoca, Romania
| | - Eva Gonzalez
- Department of Processes & Quality Management, Catalan Institute of Oncology, Barcelona, Spain
| | - Debora Beldì
- Department of Radiation Oncology, University Hospital “Maggiore della Carità”, Novara, Italy
| | - Ferran Guedea
- Department of Radiation Oncology, Catalan Institute of Oncology, Barcelona, Spain
| |
Collapse
|
2
|
González JM, de Castro FJ, Barrueco M, Cordovilla R, Fernández JL, Gómez FP, Moreno de Vega B, Ramos J, Serrano AR. [Delays in the diagnosis of lung cancer]. Arch Bronconeumol 2004; 39:437-41. [PMID: 14533992 DOI: 10.1016/s0300-2896(03)75425-8] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE To study the clinical and demographic factors associated with delays in the diagnosis of lung cancer. PATIENTS AND METHODS A 2-year prospective study of patients admitted to the respiratory medicine ward with a suspected diagnosis of lung cancer. We studied demographic factors, health care received, place of residence, and delays in carrying out diagnostic procedures. The following diagnostic time periods were defined: consultation (from first symptom to first medical visit), middle period (from first medical visit to hospital admission) and diagnostic (from hospital admission to histological diagnosis and clinical staging). RESULTS One hundred thirteen patients with a mean age of 65 years (range, 36-90), 103 men and 10 women, were studied. The most frequent symptoms leading to consultation were coughing (10.6%), hemoptysis (19.5%), chest pain (26.5%), and shortness of breath (9.7%). First visits were to a primary care physician for 72%, to the hospital emergency room for 22%, or to a pulmonologist for 6%. Forty-four percent of the patients visited the doctor 2 or 3 times. The mean SD, numbers of days for the different time periods were as follows: consultation, 30.3 60; diagnosis, 18.6 19; middle period 37.9 63. The mean total time from first symptom to diagnosis was 85.7 87 days. The middle period, the time in hospital until diagnosis, and the total time were shorter when patients were referred by the primary care physician to the emergency room or were directly admitted to the hospital (P<.001). Only 25.7% of the staged lung cancers were operable. CONCLUSIONS Delays in lung cancer diagnosis are long. The attitudes of primary care physicians and their relations with specialized care providers are crucial for reducing delays.
Collapse
Affiliation(s)
- J M González
- Servicio de Neumología. Hospital Universitario de Salamanca. Salamanca. Spain
| | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Collares-Pereira MJ, Serrano AR. Karyological analysis of Cylindera trisignata (Latreille & Dejean, 1822) from Portugal (Coleoptera, Cicindelidae). Genetica 1990; 82:79-83. [PMID: 2076823 DOI: 10.1007/bf00124635] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Cellular suspensions of germinal tissues of Cylindera trisignata provided the definition of its karyotype: 2n = 23 and 2n = 26 for the males and females respectively. This Palearctic species has a sex chromosome system of the X1X2X3X4Y/X1X1X2X2X3X3X4X4 type, only found until now in Cicindela maroccana pseudomaroccana. The heterosomes are not well-differentiated from the general morphological standpoint. To explain the origin of the 4X condition, a mechanism of dissociation of the X chromosomes rather than an incorporation of autosomal segments is proposed. However, based on the occurrence of distinct ploidy levels, both in male and female cells, with a relatively high incidence for the tetraploid condition with regular autosomal bivalents, the hypothesis of a possible evolutionary role of polyploidy is suggested.
Collapse
|